From the 5/7/2021 release of VAERS data:
This is VAERS ID 962567
| Days after vaccination:||21
|Vaccination / Manufacturer
||Lot / Dose
||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH
||EK9231 / 1
||LA / IM
Administered by: Private Purchased by: ?
Symptoms: Guillain-Barre syndrome,
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
Extended hospital stay? No
Other Medications: Unknown. Hospitalist overseeing inpatient care
Current Illness: Unknown.
Preexisting Conditions: Hypothyroidism. Contact Doctor for more information on past medical history.
Diagnostic Lab Data: Unknown, please contact Doctor
CDC Split Type:
Write-up: Employee received first dose of Pfizer-BioNTech Covid-19 Vaccine on 12/28/20. Per Employee''s manager: Patient began experiencing symptoms of neuropathy and was admitted to the hospital as an inpatient on 1/18/21. Informed from neurologist that most likely Guillain-Barré syndrome resulted from vaccine and instructed to not receive 2nd dose of vaccine at this time.
Link To This Search Result:
2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166